Skip to main content
Premium Trial:

Request an Annual Quote

HGS Appoints Russell as Pharmacology Director

Premium

ROCKVILLE, Md.--Human Genome Sciences announced that Deborah Austin Russell joined the company as director of pharmacology earlier this month. Russell moved from Amgen, in Thousand Oaks, Calif., where she concentrated on the biological effects of novel proteins in model systems. Russell had spent five years at Synergen in Boulder, Colo., before it was acquired by Amgen. William Haseltine, HGS chairman, said Russell's strategic challenge is to link market opportunities to relevant models of disease to enhance the company's ability to move appropriate novel therapeutic protein product candidates through the development process.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.